Does Dr. HAIFAA ABDULHAQ have financial conflicts of interest?

Dr. HAIFAA ABDULHAQ (MD) has received a total of $201,993 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $193,623 in personal promotional payouts (consulting, meals, travel) and $8,371 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. HAIFAA ABDULHAQ?

According to CMS Open Payments data, Dr. HAIFAA ABDULHAQ received funding from GENENTECH USA ($58,604), F. HOFFMANN-LA ROCHE AG ($31,714), and ABBVIE ($14,838).

Does Dr. HAIFAA ABDULHAQ receive research grants or speaking fees?

Dr. HAIFAA ABDULHAQ has received $193,623 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $8,371 in clinical research grants.

DR. HAIFAA ABDULHAQ

MDReal-Time Hydrated

Specialty: Internal Medicine, Hematology & Oncology

Practice Location: FRESNO, CA 93611

NPI Number: 1508024647

LIFETIME INDUSTRY VALUE

$201,993

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ABDULHAQ is a verified Internal Medicine, Hematology & Oncology practitioner based in FRESNO, CA.

Between 2021 and 2024, Dr. ABDULHAQ had an overall industry promotional and research financial footprint of $201,993 as recorded in the federal CMS Open Payments database.

$193,623 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$8,371 was allocated to sponsored clinical trials and medical research activities.

Dr. ABDULHAQ's primary funding source is GENENTECH USA, which accounts for $58,604 (representing 29% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GENENTECH USA

Rank 1

$58,604

29%

F. HOFFMANN-LA ROCHE AG

Rank 2

$31,714

15.7%

ABBVIE

Rank 3

$14,838

7.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.